Pioneering iPSC‐Based Therapies for Dementia: Enhancing Safety and Microenvironment Integration

This project outlines a groundbreaking therapeutic strategy addressing key barriers in iPSC-based dementia treatments, including immune rejection, tumor risk, and microenvironment compatibility. By integrating safety mechanisms, optimizing the cerebral environment, and employing biosensor monitoring, this approach holds promise for personalized neurodegenerative disease care, potentially restoring cognitive function and improving quality of life.